Pasithea Therapeutics Corp. (NASDAQ: KTTA)
$5.86
-0.2000 ( -3.30% ) 4.2K
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
Market Data
Open
$5.86
Previous close
$6.06
Volume
4.2K
Market cap
$6.18M
Day range
$5.82 - $6.11
52 week range
$4.74 - $17.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 26, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
def | Proxies and info statements | 4 | May 28, 2024 |
ars | Annual reports | 1 | May 28, 2024 |
8-k | 8K-related | 14 | May 14, 2024 |
10-q | Quarterly Reports | 69 | May 14, 2024 |
4/a | Other | 1 | Apr 05, 2024 |
4/a | Other | 1 | Apr 05, 2024 |
4/a | Other | 1 | Apr 05, 2024 |
4/a | Other | 1 | Apr 05, 2024 |